New York State Common Retirement Fund Iovance Biotherapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,220,257 shares of IOVA stock, worth $9.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,220,257
Previous 1,208,867
0.94%
Holding current value
$9.1 Million
Previous $9.7 Million
18.18%
% of portfolio
0.02%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$204 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$199 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$179 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$158 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$98.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.18B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...